Advertisement

The Scientist

» clinical trials and immunology

Most Recent

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: Fat to the Rescue

Fat to the Rescue

By | January 5, 2015

Adipocytes under the skin help fight infections by producing an antimicrobial agent.

2 Comments

image: A Movable Defense

A Movable Defense

By | January 1, 2015

In the evolutionary arms race between pathogens and hosts, genetic elements known as transposons are regularly recruited as assault weapons for cellular defense.

4 Comments

image: Stress Fractures

Stress Fractures

By | January 1, 2015

Social adversity shapes humans’ immune systems—and probably their susceptibility to disease—by altering the expression of large groups of genes.

6 Comments

image: The Year in Pathogens

The Year in Pathogens

By | December 29, 2014

Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research

0 Comments

image: Repurposed Retroviruses

Repurposed Retroviruses

By | December 18, 2014

B cells have commandeered ancient viral sequences in the genome to transmit antigen signals.

0 Comments

image: Ebola Update

Ebola Update

By | December 17, 2014

Plasma-based therapy trials begin in West Africa; NIH-GSK vaccine shows promise in Phase 1; the real statistics

0 Comments

image: Ebola Update

Ebola Update

By | December 11, 2014

NIH admits new patient; joint pains stall clinical trial; U.S. grants immunity to vaccine developers; more

1 Comment

image: New NIH IRB Guidelines Proposed

New NIH IRB Guidelines Proposed

By | December 8, 2014

A draft policy from the US National Institutes of Health suggests that clinical studies performed at multiple sites should be reviewed by a single institutional review board.

0 Comments

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. How Fats Influence the Microbiome
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. Influential Cancer Biologist Dies
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
Life Technologies